100 related articles for article (PubMed ID: 7075587)
21. Transformation-enhancing activity of gelatin-binding fragments of fibronectin.
De Petro G; Barlati S; Vartio T; Vaheri A
Proc Natl Acad Sci U S A; 1981 Aug; 78(8):4965-9. PubMed ID: 6458038
[TBL] [Abstract][Full Text] [Related]
22. NH2-terminal sequences of DNA-, heparin-, and gelatin-binding tryptic fragments from human plasma fibronectin.
Pande H; Shively JE
Arch Biochem Biophys; 1982 Jan; 213(1):258-65. PubMed ID: 7059179
[No Abstract] [Full Text] [Related]
23. Effect of sodium oleate on the hydrolysis of human plasma fibronectin by proteinases.
Stanislawski L; Hornebeck W
Biochem Int; 1988 Apr; 16(4):661-70. PubMed ID: 3291875
[TBL] [Abstract][Full Text] [Related]
24. Cathepsin G increases MMP expression in normal human fibroblasts through fibronectin fragmentation, and induces the conversion of proMMP-1 to active MMP-1.
Son ED; Kim H; Choi H; Lee SH; Lee JY; Kim S; Closs B; Lee S; Chung JH; Hwang JS
J Dermatol Sci; 2009 Feb; 53(2):150-2. PubMed ID: 18835135
[No Abstract] [Full Text] [Related]
25. DNA-binding domains of human plasma fibronectin. pH and calcium ion modulation of fibronectin binding to DNA and heparin.
Siri A; Balza E; Carnemolla B; Castellani P; Borsi L; Zardi L
Eur J Biochem; 1986 Feb; 154(3):533-8. PubMed ID: 3948864
[TBL] [Abstract][Full Text] [Related]
26. Multiple binding sites in fibronectin and the staphylococcal fibronectin receptor.
Bozzini S; Visai L; Pignatti P; Petersen TE; Speziale P
Eur J Biochem; 1992 Jul; 207(1):327-33. PubMed ID: 1385780
[TBL] [Abstract][Full Text] [Related]
27. Susceptibility of soluble and matrix fibronectins to degradation by tissue proteinases, mast cell chymase and cathepsin G.
Vartio T; Seppä H; Vaheri A
J Biol Chem; 1981 Jan; 256(1):471-7. PubMed ID: 6450204
[No Abstract] [Full Text] [Related]
28. Characterization of the opsonic and monocyte adherence functions of the specific fibronectin fragment that enhances phagocytosis of particulate activators.
Czop JK; Kadish JL; Zepf DM; Austen KF
J Immunol; 1985 Mar; 134(3):1844-50. PubMed ID: 3968434
[TBL] [Abstract][Full Text] [Related]
29. [Various properties of cathepsin G and elastase from swine peripheral blood neutrophils].
Kraeva LN; Kokriakov VN; Chesnokov IN; Iakovleva MF; Lyzlova SN
Biokhimiia; 1988 Apr; 53(4):655-62. PubMed ID: 3395645
[TBL] [Abstract][Full Text] [Related]
30. Matrix localization of tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor (TFPI-2/MSPI) involves arginine-mediated ionic interactions with heparin and dermatan sulfate: heparin accelerates the activity of TFPI-2/MSPI toward plasmin.
Liu Y; Stack SM; Lakka SS; Khan AJ; Woodley DT; Rao JS; Rao CN
Arch Biochem Biophys; 1999 Oct; 370(1):112-8. PubMed ID: 10496984
[TBL] [Abstract][Full Text] [Related]
31. The mitogenic activity of a heparin-binding fibronectin fragment (Mr 35,000) produced by cathepsin D digestion.
Savill CM; Ayad SR
Anticancer Res; 1986; 6(2):321-6. PubMed ID: 3707069
[TBL] [Abstract][Full Text] [Related]
32. Inflammation-related neutrophil proteases, cathepsin G and elastase, function as insulin-like growth factor binding protein proteases.
Gibson TL; Cohen P
Growth Horm IGF Res; 1999 Aug; 9(4):241-53. PubMed ID: 10512690
[TBL] [Abstract][Full Text] [Related]
33. Structural comparisons of fibronectins isolated from early and late passage cells.
Sorrentino JA; Millis AJ
Mech Ageing Dev; 1984 Nov; 28(1):83-97. PubMed ID: 6513615
[TBL] [Abstract][Full Text] [Related]
34. Hydrophobic properties of porcine fibronectin and its functional domains.
Hayashi-Nagai A; Kitagaki-Ogawa H; Matsumoto I; Hayashi M; Seno N
J Biochem; 1991 Jan; 109(1):83-8. PubMed ID: 2016277
[TBL] [Abstract][Full Text] [Related]
35. Binding site in human plasma fibronectin to HL-60 cells localizes in the C-terminal heparin-binding region independently of RGD and CS1.
Fujita H; Mohri H; Kanamori H; Iwamatsu A; Okubo T
Exp Cell Res; 1995 Apr; 217(2):484-9. PubMed ID: 7698249
[TBL] [Abstract][Full Text] [Related]
36. Location of a gelatin-binding region of human plasma fibronectin.
Furie MB; Frey AB; Rifkin DB
J Biol Chem; 1980 May; 255(10):4391-4. PubMed ID: 7372581
[No Abstract] [Full Text] [Related]
37. Functional domain structure of fibronectin.
Sekiguchi K; Hakomori S
Proc Natl Acad Sci U S A; 1980 May; 77(5):2661-5. PubMed ID: 6994104
[TBL] [Abstract][Full Text] [Related]
38. Biochemical and immunological characterization of three binding sites on human plasma fibronectin with different affinities for heparin.
Gold LI; Frangione B; Pearlstein E
Biochemistry; 1983 Aug; 22(17):4113-9. PubMed ID: 6615820
[No Abstract] [Full Text] [Related]
39. Further characterization of porcine plasma fibronectin which contains fucosylated carbohydrate chains.
Isemura M; Kan M; Yamaguchi Y; Munakata H; Aikawa J; Yamane I; Yosizawa Z
Biochim Biophys Acta; 1984 Jun; 799(3):276-81. PubMed ID: 6428463
[TBL] [Abstract][Full Text] [Related]
40. Co-operative domains in fibronectin.
Tatunashvili LV; Filimonov VV; Privalov PL; Metsis ML; Koteliansky VE; Ingham KC; Medved LV
J Mol Biol; 1990 Jan; 211(1):161-9. PubMed ID: 2299666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
